Micron Has Surged 207% This Year. Brace for a Steep Pullback.

Micron shares are up 207% in 2026 (through Friday close) after the company delivered Q3 fiscal 2026 revenue of $41.5B and adjusted EPS of $25.10, projecting Q4 revenue of $49B–$51B and adjusted EPS of $30B–$32B. However, the article flags that DRAM and NAND price growth is likely to slow (TrendForce: +13% to +18% for conventional DRAM and +10% to +15% for NAND in Q3), which could cap margins and stall earnings upgrades. Despite a low 5.5x one-year forward earnings multiple, Wall Street’s fiscal 2027 EPS estimate is accelerating (from $95.80 to $154.70 over three months), but only +1.2% over the latest month—raising the risk that optimism fades while capex ramps toward ~$27B in fiscal 2026 but new capacity won’t contribute until mid-2027+.

Analysis

MU is starting to look like a classic peak-revision setup: the business can stay very healthy while the stock stops working because the next increment in earnings power gets harder to prove. In memory, the equity usually tops before the cycle does; once the market stops believing estimates will keep ratcheting up, the multiple no longer needs to be expensive to de-rate. The key nuance is that HBM scarcity is bullish for the product mix, but it also concentrates wafer capacity into a single high-end lane and can mask softening in the more cyclical DRAM/NAND base.

The second-order implication is not just MU risk — it is a read-through on the AI supply chain. If memory pricing cools, GPU vendors such as NVDA may actually get relief on bill-of-materials pressure, but the bigger near-term market effect is usually on memory names whose revisions have outrun the price curve. That makes the next 1-3 months about revision momentum, not absolute demand; if sell-side FY27 numbers stop rising, the stock can underperform even if utilization stays tight.

Catalyst-wise, watch contract pricing, channel inventory, and management commentary into the next quarter; a deceleration in DRAM from very high sequential gains into low-teens would likely be enough to flatten revisions. The contrarian bull case is that supply additions are delayed and HBM ramps stay constrained longer than expected, which could keep gross margin elevated into mid-2027. Falsify the bearish view if HBM4 volumes surprise to the upside, gross margin holds at peak-like levels, or FY27 EPS estimates re-accelerate after this recent pause.

Key Decisions for Investors

• Short MU only on strength or via 1-3 month put spreads after any rally that coincides with stalled EPS revision momentum; this is a revision-risk trade, not a bankruptcy trade, so size accordingly and use a defined-risk structure.
• Pair trade: long NVDA / short MU for a relative-value expression of AI demand versus memory-cycle duration; the thesis is that NVDA retains pricing power while MU is more exposed to commodity-memory normalization over the next 1-2 quarters.
• Set a watch alert on MU if FY27 consensus EPS growth flattens for two consecutive weekly updates or if DRAM/NAND contract pricing inflects below low-teens sequential gains; that would be the trigger to add to shorts or extend put duration.
• Avoid adding to broad semis exposure via SMH/SOXX until MU confirms the next guide; if memory revisions roll over, index-level semis can see multiple compression even without a hard demand break.